165 related articles for article (PubMed ID: 27065329)
1. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
Chen CH; Chang WH; Su KY; Ku WH; Chang GC; Hong QS; Hsiao YJ; Chen HC; Chen HY; Wu R; Yang PC; Chen JJ; Yu SL
Oncogene; 2016 Oct; 35(43):5674-5685. PubMed ID: 27065329
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
[TBL] [Abstract][Full Text] [Related]
4. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
[TBL] [Abstract][Full Text] [Related]
6. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
7. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.
Wang CC; Lin SY; Lai YH; Liu YJ; Hsu YL; Chen JJ
PLoS One; 2012; 7(4):e33772. PubMed ID: 22529897
[TBL] [Abstract][Full Text] [Related]
10. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma.
Lin SY; Hsueh CM; Yu SL; Su CC; Shum WY; Yeh KC; Chang GC; Chen JJ
Nucleic Acids Res; 2010 Oct; 38(18):6148-58. PubMed ID: 20494979
[TBL] [Abstract][Full Text] [Related]
11. Acidic stress facilitates tyrosine phosphorylation of HLJ1 to associate with actin cytoskeleton in lung cancer cells.
Chen CH; Lin H; Chuang SM; Lin SY; Chen JJ
Exp Cell Res; 2010 Oct; 316(17):2910-21. PubMed ID: 20615403
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.
Zhang L; Cai X; Chen K; Wang Z; Wang L; Ren M; Huang A; Tang H
Virus Res; 2011 Apr; 157(1):76-81. PubMed ID: 21345358
[TBL] [Abstract][Full Text] [Related]
13. Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice.
Hsu MC; Luo WJ; Guo BC; Chen CH; Hu PA; Tsai YH; Su KY; Lee TS
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216179
[TBL] [Abstract][Full Text] [Related]
14. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
Lin SY; Chang HH; Lai YH; Lin CH; Chen MH; Chang GC; Tsai MF; Chen JJ
PLoS One; 2015; 10(5):e0123305. PubMed ID: 25955608
[TBL] [Abstract][Full Text] [Related]
15. HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages.
Luo WJ; Yu SL; Chang CC; Chien MH; Chang YL; Liao KM; Lin PC; Chung KP; Chuang YH; Chen JJW; Yang PC; Su KY
Elife; 2022 Aug; 11():. PubMed ID: 35983991
[TBL] [Abstract][Full Text] [Related]
16. Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.
Wang H; Liu B; Al-Aidaroos AQ; Shi H; Li L; Guo K; Li J; Tan BC; Loo JM; Tang JP; Thura M; Zeng Q
Oncogene; 2016 Jun; 35(25):3303-13. PubMed ID: 26455318
[TBL] [Abstract][Full Text] [Related]
17. SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy.
Leung EL; Tam IY; Tin VP; Chua DT; Sihoe AD; Cheng LC; Ho JC; Chung LP; Wong MP
Mol Cancer Res; 2009 Jun; 7(6):923-32. PubMed ID: 19491201
[TBL] [Abstract][Full Text] [Related]
18. Novel role of ASC as a regulator of metastatic phenotype.
Okada N; Fujii C; Matsumura T; Kitazawa M; Okuyama R; Taniguchi S; Hida S
Cancer Med; 2016 Sep; 5(9):2487-500. PubMed ID: 27350283
[TBL] [Abstract][Full Text] [Related]
19. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells.
Joannes A; Grelet S; Duca L; Gilles C; Kileztky C; Dalstein V; Birembaut P; Polette M; Nawrocki-Raby B
Mol Cancer Res; 2014 May; 12(5):775-83. PubMed ID: 24464917
[TBL] [Abstract][Full Text] [Related]
20. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
